Shukra Pharmaceuticals Ltd
NSE: BSE: 524632
₹42.09
(-1.20%)
Thu, 12 Mar 2026, 00:20 pm
Market Cap18.65B
PE Ratio63.21
Dividend0.02
Health Technology
Pharmaceuticals: Major
24.5KShukra Pharmaceuticals Financials
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total revenue | 114.64M | 204.89M | 588.34M | 745.73M | 325.87M |
| Gross profit | 16.26M | 32.27M | 66.11M | 229.55M | 154.81M |
| Operating expenses (excl. COGS) | -13.88M | -19.91M | -19.91M | -55.52M | -57.40M |
| Selling/general/admin expenses, total | -12.06M | -19.07M | -23.66M | -54.73M | -57.40M |
| Research & development | — | — | — | — | — |
| Selling/general/admin expenses, other | -12.06M | -19.07M | -23.66M | -54.73M | -57.40M |
| Other operating expenses, total | -1.82M | -837.00K | 3.76M | -787.00K | 0 |
| Operating income | 2.38M | 12.36M | 46.21M | 174.03M | 97.41M |
| Non-operating income, total | -1.40M | -2.18M | -1.79M | 24.80M | 35.96M |
| Interest expense, net of interest capitalized | -332.90K | -2.87M | -2.81M | -2.85M | -5.95M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | -1.07M | 688.00K | 1.02M | 27.65M | 41.91M |
| Non-operating interest income | 467.00K | 314.00K | 639.00K | 5.59M | 14.79M |
| Miscellaneous non-operating expense | -1.53M | 374.00K | 378.00K | 22.06M | 27.11M |
| Unusual income/expense | 0 | 0 | 0 | 0 | 0 |
| Pretax income | 978.00K | 10.18M | 44.42M | 198.83M | 133.37M |
| Taxes | 903.00K | -2.67M | -352.00K | -13.46M | -37.62M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 1.88M | 7.51M | 44.06M | 185.37M | 95.75M |
| Net income | 1.88M | 7.51M | 44.06M | 185.37M | 95.75M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 1.88M | 7.51M | 44.06M | 185.37M | 95.75M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - |
| EBITDA | 17.11M | 28.98M | 64.58M | 194.53M | 127.46M |
| EBIT | 2.38M | 12.36M | 46.21M | 174.03M | 97.41M |
| Total operating expenses | -112.26M | -192.53M | -542.13M | -571.70M | -228.47M |
| Prepaid expenses | 310.00K | 585.00K | 222.00K | 168.00K | 108.00K |
| Deferred income, current | 8.45M | 24.67M | 66.12M | 35.28M | 26.44M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — |
| Deferred tax liabilities | 32.03M | 32.60M | 32.87M | 32.73M | 34.10M |
| Deferred income, non-current | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 0 |
| Change in accrued expenses | — | — | — | — | — |
| Common dividends paid | 0 | 0 | -728.00K | -702.00K | -43.79M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800